Pioneering AI-driven solutions in drug discovery🔒 SSL Verified

Table of Contents

• ↓ Decoding biology to radically improve lives.®
• ↓ Decoding biology to radically improve lives.®
• ↓ Top Alternatives to exscientia.ai

6-Month Traffic Trend Estimate

Official Contact & Profiles

Visual representation extracted from exscientia.ai

Content Snippets from exscientia.ai

"Recursion was founded more than a decade ago on the idea that we could take images of cells and use these images to train artificial intelligence to understand the vast unknown biological space – the cellular disruptions driving disease – to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery."

"We’re using data and AI to bring better medicines to patients, faster.

The Recursion OS drug discovery and development platform has yielded an advanced pipeline of potential first-in-class and best-in-class treatments for conditions with high unmet need including aggressive cancers and rare diseases. Today, we’ve demonstrated significant improvements in speed, efficiency, and reduced costs from hit identification to IND-enabling studies compared to traditional pharmaceutical company averages."

"Our strategic partnerships allow us to accelerate the discovery of new medicines and expand our potential impact on patients via AI-drug discovery.This includes pharmaceutical partnerships with industry leaders, technology partnerships with computational titans, and next-generation data partnerships that enhance our capabilities and generative AI for pharma as one of the top AI drug discovery companies in the industry."

"Over the last decade, we have generated and aggregated one of the largest fit-for-purpose proprietary biological and chemical datasets in the world — >50 petabytes spanning phenomics, transcriptomics, proteomics, ADME, and de-identified patient data. Our automated wet lab utilizes robotics and computer vision to capture millions of cell experiments per week — enabling us to quickly make and test novel discoveries. All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly optimized molecules that fuel our pipeline of potential first-in-class and best-in-class medicines.To process all this data, we worked with NVIDIA to build biopharma’s most powerful supercomputer: BioHive-2."

Key Topics & Focus Areas for exscientia.ai:

Decoding biology to radically improve lives.®

Decoding biology to radically improve lives.®